Results 111 to 120 of about 1,797 (187)

[Systemic infection caused by <i>Magnusiomyces</i> spp. in oncohaematological patients]. [PDF]

open access: yesRev Esp Quimioter
Vargas-Herrera AI   +3 more
europepmc   +1 more source

[Relevance of genetic polymorphisms in voriconazole neurotoxicity: case report in a pediatric patient]. [PDF]

open access: yesRev Esp Quimioter
Martín-Roldán A   +3 more
europepmc   +1 more source

Steroid-Refractory Cutaneous Graft-versus-Host Disease: a Case Report [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Appeceix S   +3 more
europepmc   +1 more source

Four-month-old infant with chronic granulomatous disease and invasive aspergillosis with bone involvement [PDF]

open access: yesBiomedica
Gómez-Tello H   +6 more
europepmc   +1 more source

Description of the colonizing mycobiota of endotracheal tubes from patients admitted to two intensive care units in Bogotá, Colombia [PDF]

open access: yesBiomedica, 2023
Huertas MG   +7 more
europepmc   +1 more source

Uso de voriconazol en el período neonatal. Reporte de dos casos

open access: yes, 2011
 Serious mycotic infections are now more frequent in the intensive care units and they increase morbidity and mortality rates. New antifungal agents have been developed in recent years, including voriconazole.
Ruiz Montes, Miguel Antonio   +3 more
core  

[Visual diagnosis for experts]. [PDF]

open access: yesMed Klin Intensivmed Notfmed
Arheilger L   +6 more
europepmc   +1 more source

Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study. [PDF]

open access: yesRev Esp Quimioter
Gómez-Barral L   +4 more
europepmc   +1 more source

[Drug-drug interactions in critically ill patients]. [PDF]

open access: yesMed Klin Intensivmed Notfmed
Bellmann R, Weiler S.
europepmc   +1 more source

Home - About - Disclaimer - Privacy